Prostar
Payments companies reported to CMS as associated with Prostar. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Prostar, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Prostar
These are the largest totals companies reported as associated with Prostar. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Corl | Cincinnati, OH | Interventional Cardiology | $16,500.00 |
| Brian Derubertis | New York, NY | Vascular Surgery | $14,831.55 |
| Nicolas Mouawad | West Branch, MI | Vascular Surgery | $3,399.33 |
| Prakash Krishnan | New York, NY | Interventional Cardiology | $3,288.99 |
| George Chrysant | Oklahoma City, OK | Interventional Cardiology | $3,029.39 |
| Trisha Gomez | Saint Joseph, MI | Cardiovascular Disease | $2,601.53 |
| Derek Kirby | Fort Campbell, KY | General Practice | $2,535.54 |
| Melissa D'Andrea | Tucson, AZ | Vascular Surgery | $2,485.78 |
| Christian Bianchi | Loma Linda, CA | Surgery | $2,461.53 |
| Sandeep Banga | Carbondale, IL | Interventional Cardiology | $2,400.89 |
Prescribed Prostar?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.